Trials / Completed
CompletedNCT04065880
Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative prolonged air leak (PAL), referring to the passage of air from the lung parenchyma into the pleural space, is one of the most frequent postoperative complications after lung resection. To control air leak, there are two different products certified since years: TachoSil® and Neoveil®. This study is to investigate the difference of TachoSil® and Neoveil® in patients with PAL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | TachoSil® | topical absorbable fibrin sealant patch applied directly on the lung area with air fistula. |
| OTHER | Neoveil® | bioabsorbable soft-tissue reinforcement material applied on the normal shape of the lung at the end of the operation. |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-31
- First posted
- 2019-08-22
- Last updated
- 2023-05-15
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04065880. Inclusion in this directory is not an endorsement.